KR960006917A - Terpenadine and Pseudohydrophedrine Hydrochloride Composite Pellet Composition - Google Patents

Terpenadine and Pseudohydrophedrine Hydrochloride Composite Pellet Composition Download PDF

Info

Publication number
KR960006917A
KR960006917A KR1019940020000A KR19940020000A KR960006917A KR 960006917 A KR960006917 A KR 960006917A KR 1019940020000 A KR1019940020000 A KR 1019940020000A KR 19940020000 A KR19940020000 A KR 19940020000A KR 960006917 A KR960006917 A KR 960006917A
Authority
KR
South Korea
Prior art keywords
terpenadine
pseudoephedrine hydrochloride
pellet
pellet composition
composite pellet
Prior art date
Application number
KR1019940020000A
Other languages
Korean (ko)
Inventor
김현수
민병희
최윤환
조항범
Original Assignee
김태훈
주식회사 유한양행
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김태훈, 주식회사 유한양행 filed Critical 김태훈
Priority to KR1019940020000A priority Critical patent/KR960006917A/en
Publication of KR960006917A publication Critical patent/KR960006917A/en

Links

Abstract

본 발명은 염산 슈도에페드린 일부와 테르페나딘을 일정량의 비등제를 함유시켜 제조한 펠렛(A)과 서방성염산 슈도에페드린의 펠렛(B)을 함께 캅셀에 충전시킨 것을 특징으로 하는 테르페나딘과 염산슈도에페드린의 복합 펠렛 조성물에 관한 것이다.The present invention relates to a composite pellet composition of terpenadine and pseudoephedrine hydrochloride, wherein a capsule prepared by containing a portion of pseudoephedrine hydrochloride and terpenadine containing a certain amount of a boiling agent and pellets (B) of sustained-release hydrochloric acid pseudoephedrine are contained in a capsule. It is about.

Description

테르페나딘과-염산슈도에페드린의 복합 펠렛(pellet) 조성물Complex pellet composition of terfenadine and pseudoephedrine hydrochloride

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (7)

염산슈도에페드린 일부와 테르페나딘을 일정량의 비등제를 함유시켜 제조한 펠렛(A)과 염산슈도에페드린의 서방성 펠렛(B)을 함께 캅셀에 충전시킨 것을 특징으로 하는 테르페나딘과 염산슈도에페드린의 복합 펠렛 조성물.A composite pellet composition of terpenadine and pseudoephedrine hydrochloride, characterized in that a capsule (S) prepared by containing a portion of sudoephedrine hydrochloride and terpenadine containing a certain amount of a boiling agent and sustained-release pellets (B) of pseudoephedrine hydrochloride are filled together in a capsule. 제1항에 있어서, 펠렛(A)에 함유된 염산 슈도에페드린의 함량이 총 염산슈도에페드린 중량에 대해 5-30%임을 특징으로 하는 테르페나딘과 염산슈도에페드린의 복합 펠렛 조성물.The composite pellet composition of terpenadine and pseudoephedrine hydrochloride according to claim 1, wherein the content of pseudoephedrine hydrochloride in the pellet (A) is 5-30% based on the total weight of pseudoephedrine hydrochloride. 제1항에 있어서, 펠렛(A에 함유된 비등제가 탄산수소나트륨, 탄산나트륨 또는 이들의 혼합물인 것을 특징으로 하는 테르페나딘과 염산슈도에페드린의 복합 펠렛 조성물.The composite pellet composition according to claim 1, wherein the pellet (the boiling agent contained in A is sodium hydrogen carbonate, sodium carbonate or a mixture thereof). 제3항에 있어서, 비등제의 함량이 총 펠렛(A)중량에 대해 5-50%임을 특징으로 하는 테르페나딘과 염산슈도에페드린의 복합 펠렛 조성물.4. The composite pellet composition of terfenadine and pseudoephedrine hydrochloride according to claim 3, wherein the content of the boiling agent is 5-50% by weight of the total pellet (A). 제1항에 있어서 서방성 염산 슈도에페드린 펠렛(B)이 수불용성 물질로 피막시킨 피막형 펠렛인 것을 특징으로 하는 테르페나딘과 염산슈도에페드린의 복합 펠렛 조성물.The composite pellet composition of terpenadine and pseudoephedrine hydrochloride according to claim 1, wherein the sustained-release pseudoephedrine hydrochloride (B) is a coated pellet coated with a water-insoluble substance. 제5항에 있어서, 수불용성 물질이 에칠셀룰로오스, 히드로제네이티드카스터오일, 또는 슈어릴리즈(SureleaseColorncon사)인 것을 특징으로 하는 테르페나딘과 염산슈도에페드린의 복합 펠렛 조성물.The method of claim 5, wherein the water insoluble substance is ethylcellulose, hydrogenated castor oil, or Surelease. Colorncon Co.), a composite pellet composition of terpenadine and pseudoephedrine hydrochloride. 제5항 또는 제6항에 있어서,수불용성 물질의 함량이 펠렛(B)에 대하여 5 내지 30중량%인 것을 특징으로 하는 테르페나딘과 염산슈도에페드린의 복합 펠렛 조성물.The complex pellet composition according to claim 5 or 6, wherein the content of the water-insoluble substance is 5 to 30% by weight based on the pellet (B). ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019940020000A 1994-08-13 1994-08-13 Terpenadine and Pseudohydrophedrine Hydrochloride Composite Pellet Composition KR960006917A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019940020000A KR960006917A (en) 1994-08-13 1994-08-13 Terpenadine and Pseudohydrophedrine Hydrochloride Composite Pellet Composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940020000A KR960006917A (en) 1994-08-13 1994-08-13 Terpenadine and Pseudohydrophedrine Hydrochloride Composite Pellet Composition

Publications (1)

Publication Number Publication Date
KR960006917A true KR960006917A (en) 1996-03-22

Family

ID=66698204

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940020000A KR960006917A (en) 1994-08-13 1994-08-13 Terpenadine and Pseudohydrophedrine Hydrochloride Composite Pellet Composition

Country Status (1)

Country Link
KR (1) KR960006917A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251427B1 (en) 1999-02-23 2001-06-26 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and psuedoephedrine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251427B1 (en) 1999-02-23 2001-06-26 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and psuedoephedrine

Similar Documents

Publication Publication Date Title
EP0257386A3 (en) Gelatin capsules and preparation thereof
DE3672096D1 (en) GELATINE CAPSULES AND METHOD FOR THEIR PRODUCTION.
KR890004689A (en) Nitroglycerin spray
AR001665A1 (en) Clear or translucent tack free gel or antiperspirant stick composition and method of manufacture
KR850002954A (en) Gelatin capsules
FI981654A0 (en) Stable preparations containing fat-soluble substances
EA200000506A1 (en) COMPOSITION TO REDUCE WEIGHT
KR900012612A (en) Pharmaceutical composition
KR890014104A (en) Pharmaceutical composition especially acting on the heart and cardiovascular system and its manufacturing process
KR890009385A (en) Encapsulating Antifungal Compositions
KR960006917A (en) Terpenadine and Pseudohydrophedrine Hydrochloride Composite Pellet Composition
Boily et al. Developmental and seasonal changes in resting metabolic rates of captive female grey seals
KR960006922A (en) Terpenadine-containing Pellet Compositions
Watts et al. Mineral lick use and movement in a remnant desert bighorn sheep population
KR920018076A (en) New polypeptide
Pouliot Catecholamine Excretion in Adreno‐Demedullated Rats Exposed to Gold after Chronic Guanethidine Treatment
Navarro et al. Effect of temperature on permeability and drinking rates of the metanauplii of the brine shrimp Artemia sp.
Stenstrom et al. Inhibition by ethanol of forskolin-stimulated adenylate cyclase in a murine neuroblastoma clone (N1E-115)
KR890011594A (en) Pharmaceutical composition of 4-aroylimidazol-2-one
RU97106965A (en) GEL-FORMING COMPOSITION FOR INSULATION OF WATER DEPOSITS IN A WELL
Wildgust et al. Effect of Cd on accumulation and loss of 210Po in the mussel Mytilus edulis
KR910700043A (en) Stress dispersion method in tableting
KR970014585A (en) Antifouling agent of feed pellets for fish farming
RU98105049A (en) ANTISISCHEMIC AND ANTIATHEROSCLEROTIC MEDICINE
Reynolds et al. Chemical control of Leptoconops spinosifrons in the Seychelles

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application